Literature DB >> 26879139

Amphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter.

D O Sviridov1, S K Drake2, L A Freeman3, A T Remaley3.   

Abstract

ApoA-I mimetics are short synthetic n class="Chemical">peptides that contain an amphipathic α-helix and stimulate cholesterol efflux by the ABCA1 transporter in a detergent-like extraction mechanism. We investigated the use of amphipathic peptides with a polypro helix for stimulating cholesterol efflux by ABCA1. Polypro peptides were synthesized with modified prolines, containing either a hydrophobic phenyl group (Prop) or a polar N-acetylgalactosamine (Prog) attached to the pyrrolidine ring and were designated as either PP-2, 3, 4, or 5, depending on the number of 3 amino acid repeat units (Prop-Prog-Prop). Based on molecular modeling, these peptides were predicted to be relatively rigid and to bind to a phospholipid bilayer. By CD spectroscopy, PP peptides formed a Type-II polypro helix in an aqueous solution. PP-2 was inactive in promoting cholesterol efflux, but peptides with more than 2 repeat units were active. PP-4 showed a similar Vmax as a much longer amphipathic α-helical peptide, containing 37 amino acids, but had a Km that was approximately 20-fold lower. PP peptides were specific in that they did not stimulate cholesterol efflux from cells not expressing ABCA1 and were also non-cytotoxic. Addition of PP-3, 4 and 5 to serum promoted the formation of smaller size HDL species (7 nM) and increased its capacity for ABCA1-dependent cholesterol efflux by approximately 20-35% (p < 0.05). Because of their relatively small size and increased potency, amphipathic peptides with a polypro helix may represent an alternative structural motif for the development of apoA-I mimetic peptides.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABCA1; Cardiovascular disease; Cholesterol; Peptides; Polypro

Mesh:

Substances:

Year:  2016        PMID: 26879139      PMCID: PMC4819318          DOI: 10.1016/j.bbrc.2016.02.032

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field.

Authors:  Devleena Shivakumar; Joshua Williams; Yujie Wu; Wolfgang Damm; John Shelley; Woody Sherman
Journal:  J Chem Theory Comput       Date:  2010-04-14       Impact factor: 6.006

2.  Western blots.

Authors:  Lita A Freeman
Journal:  Methods Mol Biol       Date:  2013

Review 3.  Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.

Authors:  Anisha A D'Souza; Padma V Devarajan
Journal:  J Control Release       Date:  2015-02-18       Impact factor: 9.776

Review 4.  Polyproline-II helix in proteins: structure and function.

Authors:  Alexei A Adzhubei; Michael J E Sternberg; Alexander A Makarov
Journal:  J Mol Biol       Date:  2013-03-16       Impact factor: 5.469

5.  5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.

Authors:  Marcelo J A Amar; Wilissa D'Souza; Scott Turner; Stephen Demosky; Denis Sviridov; John Stonik; Jayraz Luchoomun; Jason Voogt; Marc Hellerstein; Dmitri Sviridov; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2010-05-19       Impact factor: 4.030

6.  Apolipoprotein specificity for lipid efflux by the human ABCAI transporter.

Authors:  A T Remaley; J A Stonik; S J Demosky; E B Neufeld; A V Bocharov; T G Vishnyakova; T L Eggerman; A P Patterson; N J Duverger; S Santamarina-Fojo; H B Brewer
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

Review 7.  The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins.

Authors:  J P Segrest; D W Garber; C G Brouillette; S C Harvey; G M Anantharamaiah
Journal:  Adv Protein Chem       Date:  1994

8.  Probing polyproline structure and dynamics by photoinduced electron transfer provides evidence for deviations from a regular polyproline type II helix.

Authors:  Sören Doose; Hannes Neuweiler; Hannes Barsch; Markus Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

Review 9.  HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.

Authors:  Alan T Remaley; Marcelo Amar; Dmitri Sviridov
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-10

10.  Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT.

Authors:  Diego Lucero; Denis Sviridov; Denis Svidirov; Lita Freeman; Graciela I López; Eduardo Fassio; Alan T Remaley; Laura Schreier
Journal:  Atherosclerosis       Date:  2015-07-10       Impact factor: 5.162

View more
  5 in total

1.  Understanding the antimicrobial properties/activity of an 11-residue Lys homopeptide by alanine and proline scan.

Authors:  P Carvajal-Rondanelli; M Aróstica; C A Álvarez; C Ojeda; F Albericio; L F Aguilar; S H Marshall; F Guzmán
Journal:  Amino Acids       Date:  2018-02-21       Impact factor: 3.520

2.  ATP-binding cassette transporter A1: A promising therapy target for prostate cancer.

Authors:  Ting Xiong; Gang Xu; Xue-Long Huang; Kai-Qiang Lu; Wei-Quan Xie; Kai Yin; Jian Tu
Journal:  Mol Clin Oncol       Date:  2017-11-15

Review 3.  High-density lipoproteins, reverse cholesterol transport and atherogenesis.

Authors:  Henry J Pownall; Corina Rosales; Baiba K Gillard; Antonio M Gotto
Journal:  Nat Rev Cardiol       Date:  2021-04-08       Impact factor: 32.419

4.  Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux.

Authors:  Rafique M Islam; Mohsen Pourmousa; Denis Sviridov; Scott M Gordon; Edward B Neufeld; Lita A Freeman; B Scott Perrin; Richard W Pastor; Alan T Remaley
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

Review 5.  Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases.

Authors:  Anna Wolska; Mart Reimund; Denis O Sviridov; Marcelo J Amar; Alan T Remaley
Journal:  Cells       Date:  2021-03-08       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.